المؤلفون: Mao, Ziling, Baker, Jacqueline Roshelli, Takeuchi, Masayoshi, Hyogo, Hideyuki, Tjønneland, A. Marie, Eriksen, Anne Kirstine, Severi, Gianluca, Rothwell, Joseph A., Laouali, Nasser, Katzke, Verena Andrea, Kaaks, Rudolf J., Schulze, Matthias Bernd, Palli, Domenico, Sieri, Sabina, de Magistris, Maria, Tumino, Rosario, Sacerdote, Carlotta, Derksen, Jeroen W.G., Gram, Inger Torhild, Skeie, Guri, Sandanger, Torkjel Manning, Quirós, José Ramón, Crous-Bou, Marta, Sánchez, Maria José, Amiano, Pilar, Colorado-Yohar, Sandra Milena, Guevara, Marcela M., Harlid, Sophia, Johansson, Ingegerd, Perez-Cornago, Aurora, Freisling, Heinz, Gunter, Marc J.R., Weiderpass, Elisabete, Heath, Alicia K., Aglago, Elom Kouassivi, Jenab, Mazda, Fedirko, Veronika

المساهمون: Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Cancer Prevention and Research Institute of Texas, CPRIT, International Arctic Research Center, University of Alaska, Fairbanks, IARC, Kræftens Bekæmpelse, DCS, Deutsches Krebsforschungszentrum, DKFZ, Centre International de Recherche sur le Cancer, CIRC, National Research Council, NRC, World Cancer Research Fund International, WCRF: WCRF 2015/1391, University of Maryland School of Public Health, SPH, Medical Research Council, MRC: 1000143, MC‐UU_12015/1, MR/M012190/1, MR/N003284/1, Cancer Research UK, CRUK: 14136, C8221/A29017, C864/A14136, RR200056, World Cancer Research Fund, WCRF, University of Cambridge, Imperial College London, Institut National de la Santé et de la Recherche Médicale, Inserm, Bundesministerium für Bildung und Forschung, BMBF, Cancerfonden, Ministerie van Volksgezondheid, Welzijn en Sport, VWS, Ligue Contre le Cancer, Vetenskapsrådet, VR, Instituto de Salud Carlos III, ISCIII, Deutsche Krebshilfe, Rijksinstituut voor Volksgezondheid en Milieu, RIVM, Institut Gustave-Roussy, Mutuelle Générale de l'Education Nationale, MGEN, Consejería de Salud y Familias, Junta de Andalucía, NIHR Imperial Biomedical Research Centre, BRC, Wereld Kanker Onderzoek Fonds, WKOF, Funding WCRF 2015/1391, PI: Mazda Jenab was obtained from Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme. The coordination of EPIC is financially supported by International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). The national cohorts are supported by Danish Cancer Society (Denmark), Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France), German Cancer Aid, German Cancer Research Center (DKFZ), German Institute of Human Nutrition Potsdam‐Rehbruecke (DIfE), Federal Ministry of Education and Research (BMBF) (Germany), Associazione Italiana per la Ricerca sul Cancro‐AIRC‐Italy, Compagnia di SanPaolo and National Research Council (Italy), Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands), Health Research Fund (FIS) ‐ Instituto de Salud Carlos III (ISCIII), Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology ‐ ICO (Spain), Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden), Cancer Research UK (14136 to EPIC‐Norfolk, C8221/A29017 to EPIC‐Oxford), Medical Research Council (1000143 to EPIC‐Norfolk, MR/M012190/1 to EPIC‐Oxford). (United Kingdom). The EPIC‐Norfolk study (doi:10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MC‐UU_12015/1) and Cancer Research UK (C864/A14136). Veronika Fedirko is supported by the Cancer Prevention and Research Institute of Texas (CPRIT) Rising Stars Award (Grant ID RR200056). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Grant support, We are grateful to all the participants who have been part of the project and to the many members of the study teams at the University of Cambridge, EPIC Asturias and EPIC Aarhus who have enabled this research. We thank the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, for their contribution and ongoing support to the EPIC Study. We would also like to posthumously thank Dr H. Bas Bueno de Mesquita, former Senior Scientist from the RIVM, for his contributions to this work., Cancer Prevention and Research Institute of Texas (CPRIT) Rising Stars Award, Wereld Kanker Onderzoek Fonds (WKOF), World Cancer Research Fund International, Grant/Award Number: WCRF 2015/1391, International Agency for Research on Cancer, NIHR Imperial Biomedical Research Centre, Danish Cancer Society, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale, German Cancer Aid, German Cancer Research Center, German Institute of Human Nutrition Potsdam‐Rehbruecke (DIfE), Federal Ministry of Education and Research, Associazione Italiana per la Ricerca sul Cancro‐AIRC‐Italy, Compagnia di SanPaolo, National Research Council, Dutch Ministry of Public Health, Welfare and Sports (VWS), Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund, Statistics Netherlands (The Netherlands), Fondo de Investigaciones Sanitarias (FIS, Spanish Health Research Fund), Instituto de Salud Carlos III, Regional Governments of Andalucía, Catalan Institute of Oncology ‐ ICO, Swedish Cancer Society, Swedish Research Council, County Councils of Skåne and Västerbotten, Medical Research Council, Grant/Award Numbers: MC‐UU_12015/1, MR/N003284/1, MR/M012190/1, 1000143, Cancer Research UK, Grant/Award Numbers: C864/A14136, C8221/A29017, 14136, Cancer Prevention and Research Institute of Texas, Grant/Award Number: RR200056 Funding information ε ε δ

المصدر: ISSN: 0020-7136.

مصطلحات موضوعية: advanced glycation end products, colorectal cancer, glyceraldehyde-derived advanced glycation end products, mortality, prospective study, [SDV.CAN]Life Sciences [q-bio]/Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36715363; hal-04106328; https://hal.science/hal-04106328Test; PUBMED: 36715363

الإتاحة: https://doi.org/10.1002/ijc.34449Test
https://hal.science/hal-04106328Test

المؤلفون: Mao, Ziling, Baker, Jacqueline Roshelli, Takeuchi, Masayoshi, Hyogo, Hideyuki, Tjønneland, A. Marie, Eriksen, Anne Kirstine, Severi, Gianluca, Rothwell, Joseph A., Laouali, Nasser, Katzke, Verena Andrea, Kaaks, Rudolf J., Schulze, Matthias Bernd, Palli, Domenico, Sieri, Sabina, de Magistris, Maria, Tumino, Rosario, Sacerdote, Carlotta, Derksen, Jeroen W.G., Gram, Inger Torhild, Skeie, Guri, Sandanger, Torkjel Manning, Quirós, José Ramón, Crous-Bou, Marta, Sánchez, Maria José, Amiano, Pilar, Colorado-Yohar, Sandra Milena, Guevara, Marcela M., Harlid, Sophia, Johansson, Ingegerd, Perez-Cornago, Aurora, Freisling, Heinz, Gunter, Marc J.R., Weiderpass, Elisabete, Heath, Alicia K., Aglago, Elom Kouassivi, Jenab, Mazda, Fedirko, Veronika

المساهمون: Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office Genève, Suisse (OMS / WHO), Cancer Prevention and Research Institute of Texas, CPRIT, International Arctic Research Center, University of Alaska, Fairbanks, IARC, Kræftens Bekæmpelse, DCS, Deutsches Krebsforschungszentrum, DKFZ, Centre International de Recherche sur le Cancer, CIRC, National Research Council, NRC, World Cancer Research Fund International, WCRF: WCRF 2015/1391, University of Maryland School of Public Health, SPH, Medical Research Council, MRC: 1000143, MC‐UU_12015/1, MR/M012190/1, MR/N003284/1, Cancer Research UK, CRUK: 14136, C8221/A29017, C864/A14136, RR200056, World Cancer Research Fund, WCRF, University of Cambridge, Imperial College London, Institut National de la Santé et de la Recherche Médicale, Inserm, Bundesministerium für Bildung und Forschung, BMBF, Cancerfonden, Ministerie van Volksgezondheid, Welzijn en Sport, VWS, Ligue Contre le Cancer, Vetenskapsrådet, VR, Instituto de Salud Carlos III, ISCIII, Deutsche Krebshilfe, Rijksinstituut voor Volksgezondheid en Milieu, RIVM, Institut Gustave-Roussy, Mutuelle Générale de l'Education Nationale, MGEN, Consejería de Salud y Familias, Junta de Andalucía, NIHR Imperial Biomedical Research Centre, BRC, Wereld Kanker Onderzoek Fonds, WKOF, Funding WCRF 2015/1391, PI: Mazda Jenab was obtained from Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme. The coordination of EPIC is financially supported by International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). The national cohorts are supported by Danish Cancer Society (Denmark), Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France), German Cancer Aid, German Cancer Research Center (DKFZ), German Institute of Human Nutrition Potsdam‐Rehbruecke (DIfE), Federal Ministry of Education and Research (BMBF) (Germany), Associazione Italiana per la Ricerca sul Cancro‐AIRC‐Italy, Compagnia di SanPaolo and National Research Council (Italy), Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands), Health Research Fund (FIS) ‐ Instituto de Salud Carlos III (ISCIII), Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology ‐ ICO (Spain), Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden), Cancer Research UK (14136 to EPIC‐Norfolk, C8221/A29017 to EPIC‐Oxford), Medical Research Council (1000143 to EPIC‐Norfolk, MR/M012190/1 to EPIC‐Oxford). (United Kingdom). The EPIC‐Norfolk study (doi:10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MC‐UU_12015/1) and Cancer Research UK (C864/A14136). Veronika Fedirko is supported by the Cancer Prevention and Research Institute of Texas (CPRIT) Rising Stars Award (Grant ID RR200056). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Grant support, We are grateful to all the participants who have been part of the project and to the many members of the study teams at the University of Cambridge, EPIC Asturias and EPIC Aarhus who have enabled this research. We thank the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, for their contribution and ongoing support to the EPIC Study. We would also like to posthumously thank Dr H. Bas Bueno de Mesquita, former Senior Scientist from the RIVM, for his contributions to this work., Cancer Prevention and Research Institute of Texas (CPRIT) Rising Stars Award, Wereld Kanker Onderzoek Fonds (WKOF), World Cancer Research Fund International, Grant/Award Number: WCRF 2015/1391, International Agency for Research on Cancer, NIHR Imperial Biomedical Research Centre, Danish Cancer Society, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale, German Cancer Aid, German Cancer Research Center, German Institute of Human Nutrition Potsdam‐Rehbruecke (DIfE), Federal Ministry of Education and Research, Associazione Italiana per la Ricerca sul Cancro‐AIRC‐Italy, Compagnia di SanPaolo, National Research Council, Dutch Ministry of Public Health, Welfare and Sports (VWS), Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund, Statistics Netherlands (The Netherlands), Fondo de Investigaciones Sanitarias (FIS, Spanish Health Research Fund), Instituto de Salud Carlos III, Regional Governments of Andalucía, Catalan Institute of Oncology ‐ ICO, Swedish Cancer Society, Swedish Research Council, County Councils of Skåne and Västerbotten, Medical Research Council, Grant/Award Numbers: MC‐UU_12015/1, MR/N003284/1, MR/M012190/1, 1000143, Cancer Research UK, Grant/Award Numbers: C864/A14136, C8221/A29017, 14136, Cancer Prevention and Research Institute of Texas, Grant/Award Number: RR200056 Funding information ε ε δ

المصدر: ISSN: 0020-7136.

مصطلحات موضوعية: advanced glycation end products, colorectal cancer, glyceraldehyde-derived advanced glycation end products, mortality, prospective study, [SDV.CAN]Life Sciences [q-bio]/Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36715363; hal-04106328; https://hal.science/hal-04106328Test; PUBMED: 36715363

الإتاحة: https://doi.org/10.1002/ijc.34449Test
https://hal.science/hal-04106328Test

المؤلفون: Mao, Ziling, Baker, Jacqueline Roshelli, Takeuchi, Masayoshi, Hyogo, Hideyuki, Tjønneland, A. Marie, Eriksen, Anne Kirstine, Severi, Gianluca, Rothwell, Joseph A., Laouali, Nasser, Katzke, Verena Andrea, Kaaks, Rudolf J., Schulze, Matthias Bernd, Palli, Domenico, Sieri, Sabina, de Magistris, Maria, Tumino, Rosario, Sacerdote, Carlotta, Derksen, Jeroen W.G., Gram, Inger Torhild, Skeie, Guri, Sandanger, Torkjel Manning, Quirós, José Ramón, Crous-Bou, Marta, Sánchez, Maria José, Amiano, Pilar, Colorado-Yohar, Sandra Milena, Guevara, Marcela M., Harlid, Sophia, Johansson, Ingegerd, Perez-Cornago, Aurora, Freisling, Heinz, Gunter, Marc J.R., Weiderpass, Elisabete, Heath, Alicia K., Aglago, Elom Kouassivi, Jenab, Mazda, Fedirko, Veronika

المساهمون: Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), Cancer Prevention and Research Institute of Texas, CPRIT, International Arctic Research Center, University of Alaska, Fairbanks, IARC, Kræftens Bekæmpelse, DCS, Deutsches Krebsforschungszentrum, DKFZ, Centre International de Recherche sur le Cancer, CIRC, National Research Council, NRC, World Cancer Research Fund International, WCRF: WCRF 2015/1391, University of Maryland School of Public Health, SPH, Medical Research Council, MRC: 1000143, MC‐UU_12015/1, MR/M012190/1, MR/N003284/1, Cancer Research UK, CRUK: 14136, C8221/A29017, C864/A14136, RR200056, World Cancer Research Fund, WCRF, University of Cambridge, Imperial College London, Institut National de la Santé et de la Recherche Médicale, Inserm, Bundesministerium für Bildung und Forschung, BMBF, Cancerfonden, Ministerie van Volksgezondheid, Welzijn en Sport, VWS, Ligue Contre le Cancer, Vetenskapsrådet, VR, Instituto de Salud Carlos III, ISCIII, Deutsche Krebshilfe, Rijksinstituut voor Volksgezondheid en Milieu, RIVM, Institut Gustave-Roussy, Mutuelle Générale de l'Education Nationale, MGEN, Consejería de Salud y Familias, Junta de Andalucía, NIHR Imperial Biomedical Research Centre, BRC, Wereld Kanker Onderzoek Fonds, WKOF, Funding WCRF 2015/1391, PI: Mazda Jenab was obtained from Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme. The coordination of EPIC is financially supported by International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). The national cohorts are supported by Danish Cancer Society (Denmark), Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France), German Cancer Aid, German Cancer Research Center (DKFZ), German Institute of Human Nutrition Potsdam‐Rehbruecke (DIfE), Federal Ministry of Education and Research (BMBF) (Germany), Associazione Italiana per la Ricerca sul Cancro‐AIRC‐Italy, Compagnia di SanPaolo and National Research Council (Italy), Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands), Health Research Fund (FIS) ‐ Instituto de Salud Carlos III (ISCIII), Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology ‐ ICO (Spain), Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden), Cancer Research UK (14136 to EPIC‐Norfolk, C8221/A29017 to EPIC‐Oxford), Medical Research Council (1000143 to EPIC‐Norfolk, MR/M012190/1 to EPIC‐Oxford). (United Kingdom). The EPIC‐Norfolk study (doi:10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MC‐UU_12015/1) and Cancer Research UK (C864/A14136). Veronika Fedirko is supported by the Cancer Prevention and Research Institute of Texas (CPRIT) Rising Stars Award (Grant ID RR200056). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Grant support, We are grateful to all the participants who have been part of the project and to the many members of the study teams at the University of Cambridge, EPIC Asturias and EPIC Aarhus who have enabled this research. We thank the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands, for their contribution and ongoing support to the EPIC Study. We would also like to posthumously thank Dr H. Bas Bueno de Mesquita, former Senior Scientist from the RIVM, for his contributions to this work., Cancer Prevention and Research Institute of Texas (CPRIT) Rising Stars Award, Wereld Kanker Onderzoek Fonds (WKOF), World Cancer Research Fund International, Grant/Award Number: WCRF 2015/1391, International Agency for Research on Cancer, NIHR Imperial Biomedical Research Centre, Danish Cancer Society, Institut Gustave Roussy, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale, German Cancer Aid, German Cancer Research Center, German Institute of Human Nutrition Potsdam‐Rehbruecke (DIfE), Federal Ministry of Education and Research, Associazione Italiana per la Ricerca sul Cancro‐AIRC‐Italy, Compagnia di SanPaolo, National Research Council, Dutch Ministry of Public Health, Welfare and Sports (VWS), Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund, Statistics Netherlands (The Netherlands), Fondo de Investigaciones Sanitarias (FIS, Spanish Health Research Fund), Instituto de Salud Carlos III, Regional Governments of Andalucía, Catalan Institute of Oncology ‐ ICO, Swedish Cancer Society, Swedish Research Council, County Councils of Skåne and Västerbotten, Medical Research Council, Grant/Award Numbers: MC‐UU_12015/1, MR/N003284/1, MR/M012190/1, 1000143, Cancer Research UK, Grant/Award Numbers: C864/A14136, C8221/A29017, 14136, Cancer Prevention and Research Institute of Texas, Grant/Award Number: RR200056 Funding information ε ε δ

المصدر: ISSN: 0020-7136.

مصطلحات موضوعية: advanced glycation end products, colorectal cancer, glyceraldehyde-derived advanced glycation end products, mortality, prospective study, [SDV.CAN]Life Sciences [q-bio]/Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36715363; hal-04106328; https://hal.science/hal-04106328Test; PUBMED: 36715363

الإتاحة: https://doi.org/10.1002/ijc.34449Test
https://hal.science/hal-04106328Test

المؤلفون: Mao, Ziling, Baker, Jacqueline Roshelli, Takeuchi, Masayoshi, Hyogo, Hideyuki, Tjønneland, Anne, Eriksen, Anne Kirstine, Severi, Gianluca, Rothwell, Joseph, Laouali, Nasser, Katzke, Verena, Kaaks, Rudolf, Schulze, Matthias B., Palli, Domenico, Sieri, Sabina, de Magistris, Maria Santucci, Tumino, Rosario, Sacerdote, Carlotta, Derksen, Jeroen W. G., Gram, Inger T., Skeie, Guri, Sandanger, Torkjel M., Quirós, Jose Ramón, Crous‐Bou, Marta, Sánchez, Maria‐Jose, Amiano, Pilar, Colorado‐Yohar, Sandra M., Guevara, Marcela, Harlid, Sophia, Johansson, Ingegerd, Perez‐Cornago, Aurora, Freisling, Heinz, Gunter, Marc, Weiderpass, Elisabete, Heath, Alicia K., Aglago, Elom, Jenab, Mazda, Fedirko, Veronika

المساهمون: Cancer Prevention and Research Institute of Texas, Wereld Kanker Onderzoek Fonds, Centre International de Recherche sur le Cancer, Imperial College London, NIHR Imperial Biomedical Research Centre, Kræftens Bekæmpelse, Ligue Contre le Cancer, Mutuelle Générale de l'Education Nationale, Institut National de la Santé et de la Recherche Médicale, Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, Bundesministerium für Bildung und Forschung, National Research Council, Ministerie van Volksgezondheid, Welzijn en Sport, World Cancer Research Fund, Instituto de Salud Carlos III, Cancerfonden, Vetenskapsrådet, Medical Research Council, Cancer Research UK

المصدر: International Journal of Cancer ; volume 152, issue 11, page 2257-2268 ; ISSN 0020-7136 1097-0215

الإتاحة: https://doi.org/10.1002/ijc.34449Test

المؤلفون: Tahara, Nobuhiro, Yamagishi, Sho‐ichi, Matsui, Takanori, Takeuchi, Masayoshi, Nitta, Yoshikazu, Kodama, Norihiro, Mizoguchi, Minori, Imaizumi, Tsutomu

المصدر: Cardiovascular Therapeutics ; volume 30, issue 1, page 42-48 ; ISSN 1755-5914 1755-5922

الإتاحة: https://doi.org/10.1111/j.1755-5922.2010.00177.xTest

المؤلفون: Ueda, So, Yamagishi, Sho‐ichi, Matsui, Takanori, Noda, Yoshihiro, Ueda, Shin‐ichiro, Jinnouchi, Yuko, Sasaki, Ken‐ichiro, Takeuchi, Masayoshi, Imaizumi, Tsutomu

المصدر: Cardiovascular Therapeutics ; volume 30, issue 4, page 249-254 ; ISSN 1755-5914 1755-5922

الإتاحة: https://doi.org/10.1111/j.1755-5922.2011.00264.xTest

المؤلفون: Yamagishi, Sho‐ichi, Adachi, Hisashi, Matsui, Takanori, Nakamura, Kazuo, Takeuchi, Masayoshi, Enomoto, Mika, Fukami, Ako, Otsuka, Maki, Kumagae, Shun‐ichi, Nanjo, Yasuki, Ueda, Shin‐ichiro, Imaizumi, Tsutomu

المصدر: Clinical Cardiology ; volume 32, issue 9 ; ISSN 0160-9289 1932-8737

الإتاحة: https://doi.org/10.1002/clc.20532Test

المؤلفون: Yoh, Keigyou, Hirayama, Aki, Ishizaki, Kazusa, Yamada, Akiko, Takeuchi, Masayoshi, Yamagishi, Sho‐ichi, Morito, Naoki, Nakano, Takako, Ojima, Masami, Shimohata, Homare, Itoh, Ken, Takahashi, Satoru, Yamamoto, Masayuki

المصدر: Genes to Cells ; volume 13, issue 11, page 1159-1170 ; ISSN 1356-9597 1365-2443

الإتاحة: https://doi.org/10.1111/j.1365-2443.2008.01234.xTest

المؤلفون: Yoshida, Takafumi, Yamagishi, Sho-ichi, Nakamura, Kazuo, Matsui, Takanori, Imaizumi, Tsutomu, Takeuchi, Masayoshi, Ueno, Takato, Sata, Michio

المصدر: FEBS Letters ; volume 580, issue 11, page 2788-2796 ; ISSN 0014-5793 1873-3468

الإتاحة: https://doi.org/10.1016/j.febslet.2006.04.050Test

المؤلفون: Yamagishi, Sho-ichi, Takeuchi, Masayoshi, Matsui, Takanori, Nakamura, Kazuo, Imaizumi, Tsutomu, Inoue, Hiroyoshi

المصدر: FEBS Letters ; volume 579, issue 20, page 4265-4270 ; ISSN 0014-5793 1873-3468

الإتاحة: https://doi.org/10.1016/j.febslet.2005.06.058Test